TrialBritish journal of cancer2018

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

Angiolo Gadducci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.